Changes in CD44 isoform expression during inflammatory skin disease
- 1 May 1997
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 22 (3), 128-133
- https://doi.org/10.1111/j.1365-2230.1997.tb01040.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.The Journal of cell biology, 1995
- CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.The Journal of cell biology, 1995
- Expression and modulation of CD44 variant isoforms in humansThe Journal of cell biology, 1994
- CD44 splice variants: metastases meet lymphocytesImmunology Today, 1993
- CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation.The Journal of Experimental Medicine, 1993
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- CD44 and Its Interaction with Extracellular MatrixAdvances in Immunology, 1993
- Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.Proceedings of the National Academy of Sciences, 1992
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987